Description
Votrient Pazopanib Hydrochloride 200mg Tablets is prescribed for kidney cancer and soft tissue sarcoma treatment. In cancer patients, genetic changes trigger abnormal cell production. Votrient Pazopanib Hydrochloride 200mg Tablets inhibits this process by blocking signaling pathways, halting cancer cell growth. It contains Pazopanib, classified as a Protein kinase inhibitor. Soft tissue sarcoma affects body support tissues like muscles and blood vessels. Prior to Votrient Pazopanib Hydrochloride 200mg Tablets use, liver, kidney, and heart function tests may be required, along with blood pressure monitoring. Inform your doctor about heart, kidney, or liver conditions, lung problems, thyroid issues, bleeding tendencies, or high blood pressure. Not recommended for pregnant or breastfeeding women and individuals under 18. Common side effects include indigestion, bloating, nosebleeds, dry mouth, and dizziness. Consult your doctor if symptoms persist or worsen.
